on a mobile?
 
vTap
    Loading...
 
 
Video
...GlaxoSmithKline ...Bloomberg's Allan Dodds Frank in Gaithersburg, Maryland, about a Food and Drug Administration advisory panel's decision that Glaxo's diabetes pill Avandia should remain on the ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Pharmaceutical company
Gaithersburg, Maryland
Diabetes mellitus
Combined oral contraceptive pill
Go to Feed to see what's new!
share
keep
 
 
...Bloomberg's ...GlaxoSmithKline Plc's diabetes pill Avandia and the safety of Takeda Pharmaceutical Co.'s Actos. The panel decided that Avandia should remain on the market but be accompanied by new ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Rosiglitazone
Cleveland Clinic
GlaxoSmithKline
Steven Nissen
Pharmaceutical company
Gaithersburg, Maryland
Go to Feed to see what's new!
share
keep
 
 
...Bloomberg's ...GlaxoSmithKline Plc's Avandia diabetes drug versus Takeda Pharmaceutical Co.'s Actos. Graham told a meeting of FDA advisers today that Avandia should be removed from the market ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Rosiglitazone
Pharmaceutical company
GlaxoSmithKline
Pioglitazone
Gaithersburg, Maryland
David Graham (epidemiologist)
United Kingdom
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline ...Bloomberg's Francine Lacqua from London about first-quarter earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris Pharmaceuticals Inc. ...
4 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United States
United Kingdom
Chief executive officer
Pharmaceutical company
Mergers and acquisitions
Go to Feed to see what's new!
share
keep
 
 
CNBC interviews Jean-Pierre Garnier, chief of pharmaceutical giant GlaxoSmithKline, on the company's earnings decline from generic competition.
6 months ago
The New York Times
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
CNBC
Pharmaceutical company
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter earnings reported today. A U.S. Food and Drug Administration committee meets on July 30 to review Avandia's safety after researchers said on May 21 that the diabetes pill may increase the chances of heart attacks by 43 percent. (Source: Bloomberg)
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United Kingdom
Pharmaceutical company
Chief executive officer
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use